Table 1.
Expression of dysadherin in several types of cancer and normal tissues
| Tissues | Cases | Reactivity of NCC-3G10
|
||
|---|---|---|---|---|
| ++(%) | +(%) | −(%) | ||
| Cancer tissues | ||||
| Breast | 74 | 45 (61) | 0 (0) | 29 (39) |
| Cervix | 22 | 13 (59) | 9 (41) | 0 (0) |
| Lung | 19 | 12 (63) | 1 (5) | 6 (32) |
| Esophagus | 11 | 8 (73) | 1 (5) | 2 (18) |
| Stomach | 34 | 19 (51) | 1 (3) | 15 (45) |
| Colon | 37 | 18 (52) | 9 (24) | 9 (25) |
| Bladder | 15 | 13 (87) | 2 (13) | 0 (0) |
| Normal tissues immunoreactive to NCC-3G10 | ||||
| Endothelial cells | ||||
| T cell lymphocytes | ||||
| Basal cell of squamous epithelium | ||||
Specimens were classed as −, negative; +, positive in <20% and ++, positive in >20% of cancer cells, according to the cells with cell surface membrane staining.